Monday, 29 July 2013

Improving drug acceptance and compliance in pediatric populations

Main Category: Pediatrics / Children's Health
Also Included In: Compliance
Article Date: 28 Jul 2013 - 0:00 PDT Current ratings for:
Improving drug acceptance and compliance in pediatric populations
not yet ratednot yet rated

Despite major advances in the pharmaceutical treatment of disease, many children reject medicines due to an aversion to bitter taste. As such, bitterness presents a key obstacle to the acceptance and effectiveness of beneficial drugs by children worldwide.

A new review, published online ahead of print in Clinical Therapeutics, addresses this critical problem by highlighting recent advances in the scientific understanding of bitter taste, with special attention to the sensory world of children.

Written by an interdisciplinary team of leading taste scientists from the Monell Chemical Senses Center, Florida State University, and the University of Washington, the paper focuses on applying this knowledge to improve drug acceptance and compliance in pediatric populations.

Several biological factors highlight the importance of understanding bitter taste to the successful formulation of pediatric medications. Bitter taste is thought to have evolved as a protection against toxins, as many poisons taste bitter. Because of this, it is very difficult to disguise or mask bitterness.

Compounding this problem is the fact that children, who are especially sensitive to bitterness, cannot swallow pills or tablets, which encapsulate bitterness in adult formulations.

The state-of-the-science review summarizes current knowledge on how bitter taste works from a biological perspective. In addition, the paper provides a comprehensive overview of methods used to assess taste responses in children. The authors point out critical gaps in the existing understanding of how best to measure bitterness in children, whose cognitive and perceptual abilities differ from those of adults.

"The problems associated with pediatric drug formulations are enormous and can hinder optimal therapeutic outcomes," said lead author Julie Mennella, PhD, a developmental psychobiologist at Monell. "Both the complexity of bitter taste and the unique sensory world of children contribute to this critical issue."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our pediatrics / children's health section for the latest news on this subject.

Mennella is the co-chair, and authors Alan Spector from Florida State University and Susan Coldwell of the University of Washington are members of the Taste and Flavor Working Group of the Pediatric Formulation Initiative at the Eunice Kennedy Schriver National Institute of Child Health and Human Development.

The Pediatric Formulation Initiative (PFI) was formed to address the lack of appropriate formulations in children and to identify mean to improve pediatric formulations, as mandated by the Best Pharmaceuticals for Children Act of 2002 and 2007. The PFI began in 2005 with the formation of three working groups: Scientific, Economics, and Taste and Flavor, to identify issues, gather information, and consider possible ways to overcome barriers to the development of successful pediatric drug formulations.

Danielle Reed from the Monell Center is also a co-author on the paper. Research reported in the publication was supported in part by The National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under awards number DC01187 and P30 DC011735. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Monell Chemical Senses Center

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Monell Chemical Senses Center. "Improving drug acceptance and compliance in pediatric populations." Medical News Today. MediLexicon, Intl., 28 Jul. 2013. Web.
29 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Improving drug acceptance and compliance in pediatric populations'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

No comments:

Post a Comment